Sorted By:

Relevance


PhRMA CEO Statement Following Meeting With President Trump

PhRMA  |  Blog Post


http://catalyst.phrma.org/phrma-ceo-statement-following-meeting-with-president-trump

New Spanish-language resources added to ABCs En Español

PhRMA  |  Blog Post

Learn more about how we can better engage and empower patients, and visit AccessBetterCoverage.org for other English-language resources.
http://catalyst.phrma.org/new-spanish-language-resources-added-to-abcs-en-español

Are new hep C treatments cost effective? Doctors say answer is “a resounding yes”

PhRMA  |  Blog Post

The answer is yes.
http://catalyst.phrma.org/are-new-hep-c-treatments-cost-effective-doctors-say-answer-is-a-resounding-yes

New report confirms competitive market works; Net prices for medicines increased just 2.8 percent in 2015

PhRMA  |  Blog Post

Read more on how the competitive biopharmaceutical market controls costs and encourages the development of new treatments and cures at www.phrma.org/cost.
http://catalyst.phrma.org/new-report-confirms-competitive-market-works-net-prices-for-medicines-increased-just-2.8-percent-in-2015

ICYMI: New report outlines steps for greater transparency in health care

PhRMA  |  Blog Post

Read the full NEHI report here. 
http://catalyst.phrma.org/icymi-new-report-outlines-steps-for-greater-transparency-in-health-care

Medicare Monday: New research finds drugs not a key driver of Medicare Part B costs

PhRMA  |  Blog Post

Learn more at PhRMA.org/Cost and check back with us on Medicare Monday.
http://catalyst.phrma.org/medicare-monday-new-research-finds-drugs-not-a-key-driver-of-medicare-part-b-costs

Medicare Monday: What does Medicare Part B Cover?

PhRMA  |  Blog Post

Check back with Medicare Monday for more on Part B and other aspects of Medicare next week.
http://catalyst.phrma.org/medicare-monday-what-does-medicare-part-b-cover

UK Cancer Patients Face Increasing Coverage Restrictions Due to Centralized Cost-Effectiveness Standard, New Report Shows

PhRMA  |  Press Release

Since 2000, PhRMA member companies have invested more than $550 billion in the search for new treatments and cures, including an estimated $51.1 billion in 2013 alone.
http://www.phrma.org/press-release/uk-cancer-patients-face-increasing-coverage-restrictions-due-to-centralized-cost-effectiveness-standard-new-report-shows

PhRMA Statement on the Passing of Sen. Ted Kennedy

PhRMA  |  Press Release

PhRMA members alone invested an estimated $50.3 billion in 2008 in discovering and developing new medicines.
http://www.phrma.org/press-release/phrma-statement-on-the-passing-of-sen-ted-kennedy

New report provides recommendations for securing and protecting IP

PhRMA  |  Blog Post

Without the security of a strong IP system, biopharmaceutical researchers may not have the ability to explore new areas of medical innovation and unearth the findings that will lead to the treatments of tomorrow.
http://catalyst.phrma.org/new-report-provides-recommendations-for-securing-and-protecting-ip

In the OECD other health care services will be ten times prescription medicine spending growth over next decade

PhRMA  |  Blog Post

To learn more check out our International Cost in Context information.
http://catalyst.phrma.org/in-the-oecd-other-health-care-services-will-be-ten-times-prescription-medicine-spending-growth-over-next-decade

Innovative Oncology Medicines Have Led to Impressive Gains in Patient Survivorship

PhRMA  |  Press Release

“With more than 5,000 medicines in the biopharmaceutical pipeline, including more than 3,000 potential medicines for cancer patients, the future looks bright for continued progress.
http://www.phrma.org/press-release/innovative-oncology-medicines-have-led-to-impressive-gains-in-patient-survivorship

Celebrating cardiovascular health on World Heart Day 2015

PhRMA  |  Blog Post

As we celebrate World Heart Day, it is important to remember the role of continued innovation in reducing the impact of heart disease and helping patients live longer, healthier lives.
http://catalyst.phrma.org/celebrating-cardiovascular-health-on-world-heart-day-2015

Medicare Monday: Did you know Medicare Part B uses a market-based system to pay for medicines?

PhRMA  |  Blog Post

Learn more about Medicare Part B at PhRMA.org/PartB.
http://catalyst.phrma.org/medicare-monday-did-you-know-medicare-part-b-uses-a-market-based-system-to-pay-for-medicines

New report portrays flourishing pipeline

PhRMA  |  Blog Post


http://catalyst.phrma.org/new-report-portrays-flourishing-pipeline

Strong R&D Investment the Best Bet to Slow Alzheimer’s Growing Threat

PhRMA  |  Blog Post

Building on these “failures,” researchers today are studying more than 80 medicines in development, to identify better treatments for patients.
http://catalyst.phrma.org/strong-rd-investment-the-best-bet-to-slow-alzheimers-growing-threat

Medicare Monday: Did You Know Four out of Five Part D Prescriptions Are Generic?

PhRMA  |  Blog Post


http://catalyst.phrma.org/medicaremonday-did-you-know-four-out-of-five-part-d-prescriptions-are-generic

Going boldly together: New advancements and new anniversaries

PhRMA  |  Blog Post

Researchers are continuously learning new, updated methods to enable organ recipients to live longer, more robust lives.   
http://catalyst.phrma.org/going-boldly-together-new-advancements-and-new-anniversaries

New PhRMA report: New medicines in development for autoimmune diseases offer patients hope for brighter futures

PhRMA  |  Blog Post

View the full report here.
http://catalyst.phrma.org/new-phrma-report-new-medicines-in-development-for-autoimmune-diseases-offer-patients-hope-for-brighter-futures

Paul A. Aines Named PhRMA Executive Vice President and Chief Financial Officer; Del Persinger to Retire

PhRMA  |  Press Release

Connect with PhRMA For information on how innovative medicines save lives, please visit: www.PhRMA.orgwww.FromHopetoCures.orgwww.Facebook.com/PhRMAwww.Twitter.com/PhRMA
http://www.phrma.org/press-release/paul-a-aines-named-phrma-executive-vice-president-and-chief-financial-officer-del-persinger-to-retire

ICYMI: New study shows medicines advance life expectancy for HIV patients

PhRMA  |  Blog Post

Just in the last 10 years, 15 new medicines for HIV/AIDS were approved by the U.S.
http://catalyst.phrma.org/icymi-new-study-shows-medicines-advance-life-expectancy-for-hiv-patients

ICYMI: The New Era of Medicine initiative spotlights genomics in NYC

PhRMA  |  Blog Post

Genomics technologies have allowed us to design rapid response platform technologies: those could be our best bet for the rapid production and scale up of a new vaccine.” - Ripley Ballou, Vice President of Vaccines, GSK Click here to watch the full video and learn more at innovation.org
http://catalyst.phrma.org/icymi-the-new-era-of-medicine-initiative-spotlights-genomics-in-nyc

PhRMA Foundation Launches New Web Platform

PhRMA  |  Blog Post

Later this year, we’ll be launching educational modules for health care professionals developed in partnership with the National Institutes of Health (NIH) and the American Society of Clinical Pharmacology and Therapeutics (ASCPT).
http://catalyst.phrma.org/phrma-foundation-launches-new-web-platform

Rep. Clyburn among speakers at “Research in Your Backyard” press conference

PhRMA  |  Press Release

“Clinical trials provide an important message of hope for patients who seek new treatment for unmet medical needs.
http://www.phrma.org/press-release/rep-clyburn-among-speakers-at-research-in-your-backyard-press-conference

New report highlights more than 250 vaccines in development

PhRMA  |  Blog Post

View the full report here.
http://catalyst.phrma.org/new-report-highlights-more-than-250-vaccines-in-development

You have reviewed the first 75 results out of 2024. Each page contains 25 results. You're on page 3.

prev 1 2 3 4 5 6 next